Title

Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.

Publication/Presentation Date

4-1-2008

Abstract

Adjuvant treatment options for women with ovarian cancer following optimal surgical debulking traditionally have focused on IV taxane and/or platinum-based regimens. Combining intraperitoneal (IP) with IV therapy may offer a survival advantage over IV therapy alone in selected patients. The nursing care of women receiving IP chemotherapy involves unique assessment considerations, toxicity management, and patient teaching. Current IP chemotherapy administration guidelines are in various stages of development as the challenges of safe delivery to women with ovarian cancer undergo continued investigation.

Volume

12

Issue

2

First Page

265

Last Page

271

ISSN

1092-1095

Disciplines

Medicine and Health Sciences

PubMedID

18390462

Department(s)

Patient Care Services / Nursing

Document Type

Article

Share

COinS